Matthew S. Abbott - Jun 8, 2023 Form 4 Insider Report for Chemours Co (CC)

Role
SVP, Chief Enterprise Transfor
Signature
/s/ Pauletta Brown, Attorney-in-Fact
Stock symbol
CC
Transactions as of
Jun 8, 2023
Transactions value $
-$176,190
Form type
4
Date filed
6/9/2023, 04:46 PM
Previous filing
Jun 7, 2023
Next filing
Aug 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CC Common Stock Options Exercise $129K +8.91K +29.84% $14.43 38.8K Jun 8, 2023 Direct F1
transaction CC Common Stock Sale -$305K -8.91K -22.98% $34.20 29.9K Jun 8, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CC Stock Option (Right to Buy) Options Exercise $0 -8.91K -100% $0.00* 0 Jun 8, 2023 Common Stock 8.91K $14.43 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes directly owned shares, restricted stock units and dividend equivalent units.
F2 Shares were sold in multiple transactions at a price of $34.20.
F3 Option award was granted on March 2, 2020 with vesting in three equal annual installments beginning March 2, 2021.